Quality of life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer.
CCR Drug Updates Pertuzumab : Optimizing HER 2 Blockade
No association of HLA–DRB1 and TNF alleles in Mexican patients with autoimmune hepatitis